This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Nektar Therapeutics, Oncotelic Therapeutics, Inc.. Active years: 2005-2022.
Company Filing History:
Years Active: 2005-2022
Title: Kimberly Perkins: Innovator in Immunomodulating Therapies
Introduction
Kimberly Perkins is a notable inventor based in Belmont, CA (US). She has made significant contributions to the field of immunomodulating therapies, particularly in the context of cancer treatment. With a total of 3 patents to her name, her work focuses on enhancing therapeutic approaches to combat tumors.
Latest Patents
One of her latest patents is titled "Use of VDAS to enhance immunomodulating therapies against tumors." This invention discloses methods for producing an anti-tumor effect in subjects suffering from cancer or tumors. The methods involve administering a Vascular Disrupting Agent (VDA) alongside a combretastatin agent and various antibodies, including CTLA-4, PD-1, PD-L1, and PD-L2 antibodies. The combination of these agents has shown to produce a synergistic anti-tumor effect. Another significant patent is related to "Compositions of chemically modified insulin." This invention provides active, hydrophilic polymer-modified derivatives of insulin that are suitable for lung delivery and exhibit improved pharmacokinetic and pharmacodynamic properties compared to native insulin.
Career Highlights
Throughout her career, Kimberly has worked with prominent companies such as Nektar Therapeutics and Oncotelic Therapeutics, Inc. Her innovative work has positioned her as a key figure in the development of advanced therapeutic strategies.
Collaborations
Kimberly has collaborated with notable professionals in her field, including John S Patton and Mei-chang Kuo. These collaborations have further enriched her research and development efforts.
Conclusion
Kimberly Perkins is a pioneering inventor whose work in immunomodulating therapies has the potential to significantly impact cancer treatment. Her innovative patents and collaborations highlight her dedication to advancing medical science.